Enanta Pharmaceuticals (ENTA) Financials: Revenue & Earnings

ENTA price $11.66 -0.52 -4.27%

Ticker
ENTA
Price
$11.66
Change
-0.52 -4.27%
Market cap ?
$339.60M
P/E ?
-4.83
Dividend yield ?
0.00%
Beta ?
0.96
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
53
Value
55
Quality
43
Growth
60

Stocklytics score rationale: value 55, quality 43, growth 60.

Financials

2016201720182019202020212022202320242025
882680001028140002066250002051970001224730009707400086160000792040006763500065324000

Enanta Pharmaceuticals, Inc. is a biotechnology firm dedicated to discovering and advancing small molecule therapies designed to combat a range of viral infections and various liver conditions. Its research and development efforts are primarily focused on addressing pathogens such as respiratory syncytial virus (RSV), SARS-CoV-2, human metapneumovirus (hMPV), and the hepatitis B virus (HBV). The company also holds a…

Fair value

ENTA fair value $26.38. Price $11.66. Price is 56% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 21.01M. Growth 0.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 9.60% (beta 1.0). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 29.13M. Net debt 168.76M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Compare ENTA

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-16—-0.72—14.62M
2026-08-10-0.67-0.5114.36M16.76M
2026-05-11-0.45-0.4617.16M17.03M
2026-02-09-0.42-0.5418.61M15.90M
2025-11-17-0.87-1.1315.12M15.97M
2025-08-11-0.85-1.2518.31M15.97M
2025-05-12-1.06-1.0414.93M15.96M
2025-02-10-1.05-1.1616.96M17.25M
2024-11-25-1.36-1.1667.64M17.93M
2024-08-05-1.07-1.4917.97M17.80M
2024-05-06-1.47-1.2617.05M16.52M
2024-02-07-1.58-1.1818.00M21.95M
2023-11-20-1.33-2.1118.93M20.60M
2023-08-07-1.86-2.3818.89M20.66M
2023-05-08-1.79-1.9117.80M19.18M
2023-02-07-1.39-1.5223.59M23.55M
2022-11-21-1.27-1.3720.32M23.13M
2022-08-08-1.53-1.3619.48M20.65M
2022-05-09-1.63-1.4318.72M20.67M
2022-02-08-1.48-1.1327.65M27.37M
2021-11-22-1.22-1.3123.57M27.39M
2021-08-05-1.19-1.4121.62M21.86M
2021-05-06-1.09-0.9420.13M17.87M
2021-02-08-0.41-0.8231.74M41.31M
2020-11-23-0.55-0.9223.63M12.04M
2020-08-04-0.71-0.7318.65M22.07M
2020-05-06-0.30-0.7327.62M81.94M
2020-02-060.650.5552.57M44.48M
2019-11-210.440.5351.31M61.81M
2019-08-060.330.1644.37M34.74M
2019-05-070.20-0.0839.63M15.85M
2019-02-061.251.3569.89M75.48M
2018-11-261.301.1967.20M61.52M
2018-08-070.970.9857.26M57.85M
2018-05-080.610.5344.05M38.27M
2018-02-070.590.1938.11M12.27M
2017-11-201.862.1375.93M86.95M
2017-08-07-0.44-0.497.51M8.19M
2017-05-08-0.28-0.388.96M12.16M
2017-02-08-0.26-0.1510.42M7.21M

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-08-08Rottinghaus Scott T.Sell1.47K$13.3419.57K
2026-03-11Vance TerryBuy20.00K$14.17283.40K
2026-03-11Russell LesleyBuy20.00K$14.17283.40K
2026-03-11Peterson KristineBuy20.00K$14.17283.40K
2026-03-11Hata Yujiro SBuy20.00K$14.17283.40K
2026-03-11FOLETTA MARK GBuy20.00K$14.17283.40K
2026-03-11CARTER BRUCE L ABuy20.00K$14.17283.40K
2026-02-12Kowalsky Matthew PaulBuy4.17K——
2026-02-12Kowalsky Matthew PaulSell1.90K$14.2527.10K
2026-02-12Kowalsky Matthew PaulBuy1.32K——
2026-02-12Luu BrendanBuy4.99K——
2026-02-12Luu BrendanSell3.26K$14.2546.41K
2026-02-12Luu BrendanBuy1.57K——
2026-02-12Kieffer Tara LynnBuy4.99K——
2026-02-12Kieffer Tara LynnSell3.26K$14.2546.41K
2026-02-12Kieffer Tara LynnBuy1.57K——
2026-02-12Rottinghaus Scott T.Buy5.22K——
2026-02-12Rottinghaus Scott T.Sell3.41K$14.2548.64K
2026-02-12Rottinghaus Scott T.Buy1.65K——
2026-02-12Or Yat SunBuy5.22K——
2026-02-12Or Yat SunSell3.41K$14.2548.64K
2026-02-12Or Yat SunBuy1.65K——
2026-02-12Luly Jay R.Buy15.20K——
2026-02-12Luly Jay R.Sell6.16K$14.2587.71K
2026-02-12Luly Jay R.Buy4.80K——
2025-12-05Capps Kathleen S.Sell323$14.234.60K
2025-12-05Trout Harry R. IIISell542$14.237.71K
2025-12-05Rottinghaus Scott T.Sell798$14.2311.36K
2025-12-05Luu BrendanSell1.39K$14.2319.84K
2025-12-05Kieffer Tara LynnSell2.11K$14.2329.97K
2025-12-05Or Yat SunSell2.39K$14.2334.01K
2025-12-05Luly Jay R.Sell4.74K$14.2367.49K
2025-12-02Capps Kathleen S.Sell207$13.962.89K
2025-12-02Trout Harry R. IIISell380$13.965.30K
2025-12-01Capps Kathleen S.Sell85$14.121.20K
2025-12-01Trout Harry R. IIISell105$14.121.48K
2025-12-01Luu BrendanSell498$14.127.03K
2025-12-01Kieffer Tara LynnSell753$14.1210.63K
2025-12-01Or Yat SunSell753$14.1210.63K
2025-12-01Luly Jay R.Sell1.89K$14.1226.62K
2025-11-25Capps Kathleen S.Buy3.16K——
2025-11-25Capps Kathleen S.Buy6.33K$13.6686.40K
2025-11-25Trout Harry R. IIIBuy6.46K——
2025-11-25Trout Harry R. IIIBuy12.93K$13.66176.56K
2025-11-25Luu BrendanBuy90.00K$13.661.23M
2025-11-25Kieffer Tara LynnBuy100.00K$13.661.37M
2025-11-25Kowalsky Matthew PaulBuy90.00K$13.661.23M
2025-11-25Rottinghaus Scott T.Buy110.00K$13.661.50M
2025-11-25Or Yat SunBuy110.00K$13.661.50M
2025-11-25Luly Jay R.Buy310.00K$13.664.23M
2025-08-26Capps Kathleen S.Other0——
2025-08-26Capps Kathleen S.Other5.40K$43.57235.37K
2025-08-26Capps Kathleen S.Other5.95K$48.52288.69K
2025-08-26Capps Kathleen S.Other3.48K$45.00156.69K
2025-08-26Capps Kathleen S.Other5.25K$8.9947.20K
2025-08-26Capps Kathleen S.Other5.51K$8.8348.68K
2025-08-26Capps Kathleen S.Other497$29.6814.75K
2025-08-26Capps Kathleen S.Other7.00K$81.20568.40K
2025-08-26Capps Kathleen S.Other4.91K$75.33370.17K
2025-08-26Capps Kathleen S.Other2.67K$30.0080.04K
2025-08-26Capps Kathleen S.Other8.12K$63.35514.72K
2025-08-26Trout Harry R. IIIOther0——
2025-08-26Trout Harry R. IIIOther7.11K$81.20577.33K
2025-08-26Trout Harry R. IIIOther6.05K$75.33455.60K
2025-08-26Trout Harry R. IIIOther5.57K$45.00250.69K
2025-08-26Trout Harry R. IIIOther4.99K$43.57217.28K
2025-08-26Trout Harry R. IIIOther9.07K$8.9981.58K
2025-08-26Trout Harry R. IIIOther10.18K$8.8389.85K
2025-08-26Trout Harry R. IIIOther10.00K$63.35633.50K
2025-08-08Rottinghaus Scott T.Sell2.22K$6.9915.50K
2025-03-13Vance TerryBuy15.70K$6.83107.23K
2025-03-13Russell LesleyBuy15.70K$6.83107.23K
2025-03-13Peterson KristineBuy15.70K$6.83107.23K
2025-03-13Hata Yujiro SBuy15.70K$6.83107.23K
2025-03-13FOLETTA MARK GBuy15.70K$6.83107.23K
2025-03-13CARTER BRUCE L ABuy15.70K$6.83107.23K
2025-02-12Luu BrendanBuy7.50K——
2025-02-12Luu BrendanSell3.33K$5.5918.59K
2025-02-12Kieffer Tara LynnBuy7.50K——
2025-02-12Kieffer Tara LynnSell3.33K$5.5918.59K
2025-02-12Rottinghaus Scott T.Buy9.75K——
2025-02-12Rottinghaus Scott T.Sell2.86K$5.5915.99K
2025-02-12Or Yat SunBuy9.75K——
2025-02-12Or Yat SunSell4.32K$5.5924.17K
2025-02-12MELLETT PAUL JBuy7.50K——
2025-02-12MELLETT PAUL JSell3.33K$5.5918.59K
2025-02-12Luly Jay R.Buy25.50K——
2025-02-12Luly Jay R.Sell7.48K$5.5941.84K
2025-02-12Luly Jay R.Buy45.00K$5.69256.05K
2024-12-06Kieffer Tara LynnSell2.28K$8.0618.40K
2024-12-06Luu BrendanSell2.28K$8.0618.40K
2024-12-06Rottinghaus Scott T.Sell866$8.066.98K
2024-12-06Or Yat SunSell2.59K$8.0620.88K
2024-12-06MELLETT PAUL JSell2.59K$8.0620.88K
2024-12-06Luly Jay R.Sell5.14K$8.0641.44K
2024-12-01Luu BrendanSell753$8.606.48K
2024-12-01Kieffer Tara LynnSell753$8.606.48K
2024-12-01Or Yat SunSell1.59K$8.6013.72K
2024-12-01MELLETT PAUL JSell1.59K$8.6013.72K
2024-12-01Luly Jay R.Sell3.83K$8.6032.93K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 127, holders -8 vs prior quarter. Ownership 94.75%.

HolderSharesChangeChange %Value
JUPITER TOPCO LLC3.65M3.65MNew53.25M
BLACKROCK, INC.3.24M140.68K+4.53%47.30M
KRENSAVAGE ASSET MANAGEMENT, LLC2.87M00.00%41.79M
FARALLON CAPITAL MANAGEMENT, L.L.C.2.42M-453.66K-15.80%35.26M
DEEP TRACK CAPITAL, LP1.44M-512.70K-26.20%21.06M
ADAR1 CAPITAL MANAGEMENT, LLC1.34M1.29M+2517.97%19.60M
VANGUARD CAPITAL MANAGEMENT LLC1.21M33.72K+2.86%17.67M
SPRUCE STREET CAPITAL LP1.09M156.13K+16.74%15.87M
ACADIAN ASSET MANAGEMENT LLC1.08M198.29K+22.53%15.71M
VANGUARD PORTFOLIO MANAGEMENT LLC1.01M62.59K+6.60%14.75M
GEODE CAPITAL MANAGEMENT, LLC776.63K51.57K+7.11%11.33M
MILLENNIUM MANAGEMENT LLC643.97K-238.13K-27.00%9.39M
STATE STREET CORP576.12K14.01K+2.49%8.40M
RENAISSANCE TECHNOLOGIES LLC557.60K-107.66K-16.18%8.13M
HILLSDALE INVESTMENT MANAGEMENT INC.468.00K32.49K+7.46%6.82M
GOLDMAN SACHS GROUP INC464.65K199.56K+75.28%6.77M
MORGAN STANLEY315.73K6.22K+2.01%4.60M
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.301.15K301.15KNew4.39M
CHARLES SCHWAB INVESTMENT MANAGEMENT INC301.15K6.18K+2.10%4.39M
DIMENSIONAL FUND ADVISORS LP282.68K79.43K+39.08%4.12M
NORTHERN TRUST CORP259.70K18.73K+7.77%3.79M
SUMMITTX CAPITAL, L.P.257.70K257.70KNew3.76M
AQR CAPITAL MANAGEMENT LLC256.87K-56.29K-17.97%3.75M
VANGUARD FIDUCIARY TRUST CO185.62K9.76K+5.55%2.71M
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD.153.01K27.25K+21.67%2.23M

Earnings and financials

Enanta Pharmaceuticals, Inc. (ENTA) trades at $11.66, with a market cap of $339.60M and a trailing P/E of -4.83. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2016201720182019202020212022202320242025
882680001028140002066250002051970001224730009707400086160000792040006763500065324000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Enanta Pharmaceuticals (ENTA) Financials: Revenue & Earnings

ENTA$11.66-0.52 -4.27%

$339.60M

Market Cap

-4.83

P/E

—

Forward P/E

53

Score

Price History